RNS Number : 8770L
Kosmos Energy Limited
09 June 2025
Kosmos Energy Ltd (the "Company")
PDMR Shareholding
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
9 June 2025
The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Shares in the Company:
PDMR
Date of transaction
No. of shares vested
No. of shares granted
No. of shares sold or withheld
Roy A. Franklin
4 June 2025
0
0
299
Roy A. Franklin
5 June 2025
0
96,591
0
Deanna L. Goodwin
5 June 2025
0
96,591
0
Sir John Douglas Kelso Grant
4 June 2025
0
0
275
Sir John Douglas Kelso Grant
5 June 2025
0
0
27,923
Sir John Douglas Kelso Grant
5 June 2025
0
96,591
0
Maria Moraeus Hanssen
5 June 2025
0
96,591
0
Adebayo O. Ogunlesi
5 June 2025
0
96,591
0
Steven M. Sterin
5 June 2025
0
96,591
0
J. Michael Stice
5 June 2025
0
96,591
0
The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.
This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.
Josh R. Marion
Senior Vice President, General Counsel and Corporate Secretary
CONTACT:
Investor Relations
Jamie Buckland
+44 203 954 2831
jbuckland@kosmosenergy.com
Media Relations
Thomas Golembeski
+1-214-445-9674
tgolembeski@kosmosenergy.com
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Roy A. Franklin
b)
Position / status
Director
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
299 shares withheld by the Issuer to satisfy the tax withholding requirement arising from the vesting of restricted share units granted to the reporting person under the Issuer's Long Term Incentive Plan (the "Plan").
Shares granted or vested
c)
Currency
USD
Price
0
Volume
0
Total
0
Shares sold or withheld
d)
Currency
USD
Price
1.81
Volume
299
Total
541.19
e)
Aggregated information
Price
1.81
Volume
299
Total
541.19
f)
Date of the transactions
4 June 2025
g)
Place of the transaction
NYSE
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
96,591 restricted share units granted to the reporting person on June 5, 2025 under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)
Currency
USD
Price
1.76
Volume
96,591
Total
170,000.16
Shares sold or withheld
d)
Currency
USD
Price
0
Volume
0
Total
0
e)
Aggregated information
Price
1.76
Volume
96,591
Total
170,000.16
f)
Date of the transactions
5 June 2025
g)
Place of the transaction
NYSE
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Deanna L. Goodwin
b)
Position / status
Director
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
96,591 restricted share units granted to the reporting person on June 5, 2025 under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)
Currency
USD
Price
1.76
Volume
96,591
Total
170,000.16
Shares sold or withheld
d)
Currency
USD
Price
0
Volume
0
Total
0
e)
Aggregated information
Price
1.76
Volume
96,591
Total
170,000.16
f)
Date of the transactions
5 June 2025
g)
Place of the transaction
NYSE
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Sir John Douglas Kelso Grant
b)
Position / status
Director
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
275 shares withheld by the Issuer to satisfy the tax withholding requirement arising from the vesting of restricted share units granted to the reporting person under the Issuer's Long Term Incentive Plan (the "Plan").
Shares granted or vested
c)
Currency
USD
Price
0
Volume
0
Total
0
Shares sold or withheld
d)
Currency
USD
Price
1.81
Volume
275
Total
497.75
e)
Aggregated information
Price
1.81
Volume
275
Total
497.75
f)
Date of the transactions
4 June 2025
g)
Place of the transaction
NYSE
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
27,923 shares sold to partially cover income tax liability from the vesting of restricted share units granted to the reporting person under the Plan.
Shares granted or vested
c)
Currency
USD
Price
0
Volume
0
Total
0
Shares sold or withheld
d)
Currency
USD
Price
1.81
Volume
27,923
Total
50,540.63
e)
Aggregated information
Price
1.81
Volume
27,923
Total
50,540.63
f)
Date of the transactions
5 June 2025
g)
Place of the transaction
NYSE
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
96,591 restricted share units granted to the reporting person on June 5, 2025 under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)
Currency
USD
Price
1.76
Volume
96,591
Total
170,000.16
Shares sold or withheld
d)
Currency
USD
Price
0
Volume
0
Total
0
e)
Aggregated information
Price
1.76
Volume
96,591
Total
170,000.16
f)
Date of the transactions
5 June 2025
g)
Place of the transaction
NYSE
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Maria Moraeus Hanssen
b)
Position / status
Director
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
96,591 restricted share units granted to the reporting person on June 5, 2025 under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)
Currency
USD
Price
1.76
Volume
96,591
Total
170,000.16
Shares sold or withheld
d)
Currency
USD
Price
0
Volume
0
Total
0
e)
Aggregated information
Price
1.76
Volume
96,591
Total
170,000.16
f)
Date of the transactions
5 June 2025
g)
Place of the transaction
NYSE
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Adebayo O. Ogunlesi
b)
Position / status
Director
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
96,591 restricted share units granted to the reporting person on June 5, 2025 under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)
Currency
USD
Price
1.76
Volume
96,591
Total
170,000.16
Shares sold or withheld
d)
Currency
USD
Price
0
Volume
0
Total
0
e)
Aggregated information
Price
1.76
Volume
96,591
Total
170,000.16
f)
Date of the transactions
5 June 2025
g)
Place of the transaction
NYSE
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Steven M. Sterin
b)
Position / status
Director
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
96,591 restricted share units granted to the reporting person on June 5, 2025 under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)
Currency
USD
Price
1.76
Volume
96,591
Total
170,000.16
Shares sold or withheld
d)
Currency
USD
Price
0
Volume
0
Total
0
e)
Aggregated information
Price
1.76
Volume
96,591
Total
170,000.16
f)
Date of the transactions
5 June 2025
g)
Place of the transaction
NYSE
1.
Details of PDMR / person closely associated with them ("PCA")
a)
Name
J. Michael Stice
b)
Position / status
Director
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Common Shares, par value $0.01 per share
b)
Nature of the transactions
96,591 restricted share units granted to the reporting person on June 5, 2025 under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c)
Currency
USD
Price
1.76
Volume
96,591
Total
170,000.16
Shares sold or withheld
d)
Currency
USD
Price
0
Volume
0
Total
0
e)
Aggregated information
Price
1.76
Volume
96,591
Total
170,000.16
f)
Date of the transactions
5 June 2025
g)
Place of the transaction
NYSE
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHSSUFIMEISEEM
